15Jan
BIVDA response to Parliament’s vote on the Brexit deal
Today the House of Commons voted down the EU withdrawal agreement and the framework for the future relationship.
Doris-Ann Williams, BIVDA’s Chief Executive, commented: “Today’s vote casts a shadow of uncertainty over the UK’s future relationship with the EU. The IVD industry remains anxious about access for patients to essential diagnostic tests if there is no transition period after 29 March. We therefore call for positive steps to be taken in these testing times and urge Government and policy makers to provide clarity and create sufficient space for our sector so that it is able to meet the significant challenge of ensuring the supply of essential diagnostics tests to patients through 2019.”
For a copy of BIVDA's position paper on Brexit, click here.
Related
Doris-Ann Williams, Chief Executive of BIVDA, comments on tonight's vote
Read More >
BIVDA responds to Government’s announcement of new improvements to the Accelerated Access Collabora...
Read More >
BIVDA, ABPI and CRUK have released a stakeholder briefing to clarify the new arrangements for commis...
Read More >
Commenting on the result of the General Election, BIVDA’s Chief Executive Doris-Ann Williams MBE sa...
Read More >
BIVDA has today published a report looking at the findings of its survey of point of care coordinato...
Read More >
Increasing the adoption of in vitro diagnostics (IVDs) should be a priority for the next Government,...
Read More >